Welcome to our dedicated page for Leidos Holdings news (Ticker: LDOS), a resource for investors and traders seeking the latest updates and insights on Leidos Holdings stock.
Leidos Holdings, Inc. (NYSE: LDOS) is a leading science and technology company that provides services and solutions in defense, intelligence, civil, and health markets. Headquartered in Reston, Virginia, Leidos leverages the expertise of its 47,000 employees to tackle some of the world's most pressing challenges. The company is divided into several segments, each catering to specific industries:
- National Security and Digital: Focuses on cyber, logistics, security operations, and digital transformation for defense and intelligence customers.
- Health & Civil: Delivers public health solutions, care coordination, and environmental sciences services.
- Commercial & International: Covers security enterprise solutions, commercial energy offerings, and international business.
- Defense Systems: Develops advanced space, aerial, surface, and subsurface defense systems.
Leidos reported revenues of approximately $15.4 billion for the fiscal year ending December 29, 2023. The company’s recent projects include:
- Development of C2IMERA: An advanced command and control tool for the U.S. Air Force.
- MHS GENESIS Deployment: A federal electronic health record system implemented across all Department of Defense garrison facilities.
- Mayhem Hypersonic System: Advancing air-breathing hypersonic technologies through a collaborative national team effort.
Financially, Leidos had a strong 2023 with revenues up by 7%, achieving a record net income margin of 7.1% in the first quarter of 2024. The company remains committed to innovation, operational efficiency, and addressing emerging threats in national security and health.
Leidos has been selected by the Air Force Armament Directorate (EB) and the Defense Innovation Unit (DIU) to prototype an enterprise test vehicle (ETV). This vehicle is intended to demonstrate modularity for subsystem upgrades and serve as a basis for mass production. Leidos' ETV technology merges expertise from their GBU-69 Small Glide Munition and X-61 Gremlins UAS projects. The initial flight demonstrations are expected to occur within seven months, with the best prototypes moving forward for further development. Leidos was one of four companies chosen from over 100 applicants.
Leidos has successfully completed two significant reviews—conceptual design and system requirements—for the Air Force Research Lab's (AFRL) Mayhem hypersonic system. These reviews, conducted within a digital engineering environment, demonstrate advanced designs and technologies for high-speed systems.
Utilizing a System Design Agent (SDA) construct, Leidos coordinated a team of 15 industry and academic entities, including Calspan, Draper, and Kratos Defense & Security Solutions. This collaboration facilitated modular architectures and government data rights, also fostering a workforce pipeline through the University of Michigan's Aerospace department.
Despite facing temporary funding challenges, Leidos remains committed to advancing hypersonic technologies through AFRL's Expendable Hypersonic Multi-Mission Platform Indefinite Delivery Indefinite Quantity (IDIQ) contract.
Leidos (NYSE: LDOS) will participate in the Stifel 2024 Cross Sector Insight Conference in Boston, MA. The event will feature a 'fireside chat' with CFO Chris Cage on June 5, 2024, from 9:10 a.m. to 9:40 a.m. ET. The live audio webcast will be available on the Leidos Investor Relations website, with a replay accessible for 30 days post-event.
Leidos is a Fortune 500 innovation company focusing on national security and health, with a global workforce of 47,000. The company reported annual revenues of approximately $15.4 billion for the fiscal year ending on December 29, 2023.
Leidos (NYSE: LDOS) and Elroy Air will demonstrate an autonomous Medium Aerial Resupply Vehicle – Expeditionary Logistics (MARV-EL) prototype for the U.S. Marine Corps in July 2024. This initiative, approved by the Navy and Marine Small Tactical Unmanned Aircraft Systems program office, is part of a contract to develop and test an uncrewed aircraft system for autonomous resupply missions. The demonstration will feature Elroy Air's Chaparral system at the U.S. Army Yuma Proving Grounds in Arizona. The Chaparral is a hybrid-electric vertical take-off and landing aircraft designed for efficient autonomous operations. The MARV-EL aims to provide logistics support to Marines in challenging environments. Leidos reported $15.4 billion in revenue in 2023, and Elroy Air is backed by significant venture capital and strategic investments.
Leidos, a technology innovator, secured a $631 million contract from the US Army. The DIABLO program positions Leidos as a key mission equipment provider for the Army for the next decade. The contract entails developing, acquiring, and supporting aerial intelligence, surveillance, and reconnaissance sensors and systems. Leidos' platform-agnostic solutions focus on interoperability and adaptability for enhanced battlespace awareness.
Leidos, a Fortune 500 innovation leader, secured a $206 million contract from the National Geospatial-Intelligence Agency to modernize geospatial processing. The contract, named Maru, aims to enhance efficiency and interoperability over a five-year period. Leidos will develop, sustain, and deploy analytical capabilities for geospatial processing, supporting NGA's day-to-day operations.
Leidos Holdings, Inc. reported strong financial results for the first quarter of fiscal year 2024, with revenues of $4.0 billion, up 7% year-over-year. Net income was $283 million, with EPS of $2.07. Adjusted EBITDA was $490 million, and non-GAAP diluted EPS was $2.29, showing significant growth. Cash flows from operations were $63 million, and net bookings were $3.7 billion. Leidos raised its guidance for FY24, expecting profitable growth and increased performance.
Leidos Holdings, Inc. (NYSE: LDOS) has declared a quarterly cash dividend of $0.38 per outstanding share of common stock, payable on June 28, 2024. The company, a Fortune 500® innovation company, focuses on national security and health challenges, with annual revenues of approximately $15.4 billion. Headquartered in Reston, Virginia, Leidos has a global workforce of 47,000.